Kyle McCollom
@kyle
The US gov should pay Novo $175B for the Ozempic patent (~12.5x revenue), hold it defensively, and let co’s manufacture/sell it for cheap. Would have a significant impact on annual cost of obesity ($175B) over the next decade and be a positive ROI for the US. And it’d reward Novo for its research and risk.
6 replies
2 recasts
22 reactions
the cook
@thecookabc.eth
i'm danish so i'm a novo stan, but there's no real reason to do this. you could just fix your legislation. is the federal government gonna buy every patent for 12.5x revenue every time something new and good comes along? why not just make a sustainable that protects resource scarce citizens?
1 reply
0 recast
0 reaction
the cook
@thecookabc.eth
a sustainable system*
0 reply
0 recast
0 reaction
